TY  - JOUR
T1  - Primary prevention cardiovascular disease: Better than drugs
AU  - Pippin JJ
Y1  - 2011/11/08
N1  - 10.1001/archinternmed.2010.402
JO  - Archives of Internal Medicine
SP  - 1860
EP  - 1861
VL  - 170
IS  - 20
N2  - 
In their recent critical analysis of the JUPITER (Justification for the Use of Statins in Primary Prevention) study, de Lorgeril and colleagues1 expanded the debate regarding the applications of statin therapy for primary prevention of cardiovascular disease and mortality. They identified both procedural and outcomes irregularities that led them to conclude that JUPITER does not support the use of statins for primary prevention. This conclusion was echoed by Ray et al2 in their meta-analysis of all-cause mortality in 11 randomized trials of statin therapy involving more than 65 000 high-risk primary prevention subjects.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2010.402
UR  - http://dx.doi.org/10.1001/archinternmed.2010.402
ER  -